Cytotoxic T lymphocytes from cathepsin B-deficient mice survive normally in vitro and in vivo after encountering and killing target cells

被引:42
作者
Baran, Katherine
Ciccone, Annette
Peters, Christoph
Yagita, Hideo
Bird, Phillip I.
Villadangos, Jose A.
Trapani, Joseph A.
机构
[1] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia
[2] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3052, Australia
[3] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany
[4] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan
[5] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3600, Australia
关键词
D O I
10.1074/jbc.M602007200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The lysosomal protease cathepsin B has been proposed to protect cytotoxic T lymphocytes from the membrane-disruptive effects of perforin secreted during the execution phase of target cell death. Accordingly, cathepsin B that translocates to the lymphocyte surface upon degranulation has been postulated to cleave and inactivate perforin molecules that diffuse back to the killer cell. We have found that recombinant perforin is cleaved inefficiently by cathepsin B and shows no significant reduction in its lytic activity following co-incubation. Furthermore, purified CD8+ cytotoxic T lymphocytes of cathepsin B-null gene-targeted mice were able to induce normal death of target cells both in vitro and in vivo and to survive the encounter with target cells as efficiently as cathepsin B-expressing killer cells. We conclude that cathepsin B is not essential for protection of cytotoxic lymphocytes from the toxic effects of their secreted perforin.
引用
收藏
页码:30485 / 30491
页数:7
相关论文
共 36 条
  • [1] BINDING OF PERFORIN TO MEMBRANES IS SENSITIVE TO LIPID SPACING AND NOT HEADGROUP
    ANTIA, R
    SCHLEGEL, RA
    WILLIAMSON, P
    [J]. IMMUNOLOGY LETTERS, 1992, 32 (02) : 153 - 158
  • [2] Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation
    Balaji, KN
    Schaschke, N
    Machleidt, W
    Catalfamo, M
    Henkart, PA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (04) : 493 - 503
  • [3] L-TRANS-EPOXYSUCCINYL-LEUCYLAMIDO(4-GUANIDINO)BUTANE (E-64) AND ITS ANALOGS AS INHIBITORS OF CYSTEINE PROTEINASES INCLUDING CATHEPSINS B, H AND L
    BARRETT, AJ
    KEMBHAVI, AA
    BROWN, MA
    KIRSCHKE, H
    KNIGHT, CG
    TAMAI, M
    HANADA, K
    [J]. BIOCHEMICAL JOURNAL, 1982, 201 (01) : 189 - 198
  • [4] Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1
    Coles, RM
    Mueller, SN
    Heath, WR
    Carbone, FR
    Brooks, AG
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (02) : 834 - 838
  • [5] Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation
    Deussing, J
    Roth, W
    Saftig, P
    Peters, C
    Ploegh, HL
    Villadangos, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4516 - 4521
  • [6] Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis
    Halangk, W
    Lerch, MM
    Brandt-Nedelev, B
    Roth, W
    Ruthenbuerger, M
    Reinheckel, T
    Domschke, W
    Lippert, H
    Peters, C
    Deussing, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (06) : 773 - 781
  • [7] T-CELL RECEPTOR ANTAGONIST PEPTIDES INDUCE POSITIVE SELECTION
    HOGQUIST, KA
    JAMESON, SC
    HEATH, WR
    HOWARD, JL
    BEVAN, MJ
    CARBONE, FR
    [J]. CELL, 1994, 76 (01) : 17 - 27
  • [8] SERIAL KILLING BY CYTOTOXIC T-LYMPHOCYTES - T-CELL RECEPTOR TRIGGERS DEGRANULATION, RE-FILLING OF THE LYTIC GRANULES AND SECRETION OF LYTIC PROTEINS VIA A NON-GRANULE PATHWAY
    ISAAZ, S
    BAETZ, K
    OLSEN, K
    PODACK, E
    GRIFFITHS, GM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (04) : 1071 - 1079
  • [9] GRANZYMES, A FAMILY OF SERINE PROTEASES RELEASED FROM GRANULES OF CYTOLYTIC LYMPHOCYTES-T UPON T-CELL RECEPTOR STIMULATION
    JENNE, DE
    TSCHOPP, J
    [J]. IMMUNOLOGICAL REVIEWS, 1988, 103 : 53 - 71
  • [10] JIANG S, 1990, J IMMUNOL, V144, P998